Polio

A Drop on the Tongue: Looking Back on Development of the Polio Vaccine

Retrieved on: 
Wednesday, March 10, 2021
Polio, Medical specialties, Medicine, Clinical medicine, Iron lung, Vaccine

WHITE PLAINS, N.Y., March 10, 2021 /PRNewswire-PRWeb/ -- ArtsWestchester CEO Janet Langsam looks back on the development of the polio vaccine.

Key Points: 
  • WHITE PLAINS, N.Y., March 10, 2021 /PRNewswire-PRWeb/ -- ArtsWestchester CEO Janet Langsam looks back on the development of the polio vaccine.
  • Polio was all around me as a kid growing up in Far Rockaway.
  • We all feared polio and the possibility of a life in an iron lung.
  • By the sixties, the vaccine became a drop on the tongue so easy that polio was been all but eliminated.

Global NGO expands use of PharmaJet for Polio Eradication Campaigns

Retrieved on: 
Tuesday, March 9, 2021
Infectious diseases, Pharmaceutical, Health, Medical devices, Polio, Medical specialties, Vaccination, Medicine, Clinical medicine, Polio eradication, Vaccine, Polio in Pakistan, Pulse Polio

PharmaJet , the maker of innovative, needle-free injection technology, today announced that a global NGO (Non-governmental organization) has expanded the use of its Tropis Needle-free Injection System in polio eradication campaigns.

Key Points: 
  • PharmaJet , the maker of innovative, needle-free injection technology, today announced that a global NGO (Non-governmental organization) has expanded the use of its Tropis Needle-free Injection System in polio eradication campaigns.
  • This brings the total number of children with planned or completed polio vaccinations using PharmaJet Needle-Free Injection devices to close to 3 million.
  • While there is no cure for polio, the disease can be prevented through the administration of a simple and effective vaccine.
  • That is why efforts are underway across the globe to rapidly boost immunity levels in children and protect them from polio paralysis.

Ovia Health Partners with March of Dimes to Provide Dynamic Support for Parents in the NICU

Retrieved on: 
Wednesday, March 3, 2021
Neonatology, Health, Infancy, Franklin D. Roosevelt, March of Dimes, Polio, Neonatal intensive care unit, Parenting, Nicu

Parents with children in the NICU are under immeasurable stress, often alone and without peer support.

Key Points: 
  • Parents with children in the NICU are under immeasurable stress, often alone and without peer support.
  • Through new resources, coaching, and support in the Ovia Parenting solution, Ovia and March of Dimes are seeking to provide NICU parents with guidance to reduce perinatal mood disorders and improve outcomes.
  • Nearly 9% of newborns spend time in the NICU after birth, and the experience can be traumatic for parents.
  • Having an infant in the NICU is an incredibly challenging experience for parents, said March of Dimes Sr. Director of NICU Family Support, Heather Reimer.

Chairman of the Board of Avia Solutions Group Gediminas Ziemelis: Will Israel's 300 million euros vaccination experiment open the doors for tourism?

Retrieved on: 
Monday, March 1, 2021
Vaccination, Medical specialties, Virology, Gediminas Žiemelis, Avia Solutions Group, Vaccine, Life sciences, Medicine, Vaccines, Polio

Even early into the global vaccination roll outs, Israel is already leading the way in the sheer numbers that have been vaccinated.

Key Points: 
  • Even early into the global vaccination roll outs, Israel is already leading the way in the sheer numbers that have been vaccinated.
  • To date, over 3.8 million residents have received the first vaccine dose and over 2.4 million have received the second dose.
  • These impressive numbers mean that almost 28% of Israel's population has already been vaccinated against the worst virus in living memory.
  • Gediminas Ziemelis is a founder and chairman of "Avia Solutions Group" -one of the largest aerospace servicing companies presented in more than 67 countries.

Chairman of the Board of Avia Solutions Group Gediminas Ziemelis: Will Israel's 300 million euros vaccination experiment open the doors for tourism?

Retrieved on: 
Monday, March 1, 2021
Vaccination, Medical specialties, Virology, Gediminas Žiemelis, Avia Solutions Group, Vaccine, Life sciences, Medicine, Vaccines, Polio

Even early into the global vaccination roll outs, Israel is already leading the way in the sheer numbers that have been vaccinated.

Key Points: 
  • Even early into the global vaccination roll outs, Israel is already leading the way in the sheer numbers that have been vaccinated.
  • To date, over 3.8 million residents have received the first vaccine dose and over 2.4 million have received the second dose.
  • These impressive numbers mean that almost 28% of Israel's population has already been vaccinated against the worst virus in living memory.
  • Gediminas Ziemelis is a founder and chairman of "Avia Solutions Group" -one of the largest aerospace servicing companies presented in more than 67 countries.

March Of Dimes Announces 2021 March For Babies: A Mother Of A Movement™

Retrieved on: 
Wednesday, February 24, 2021
Franklin D. Roosevelt, March of Dimes, Polio

"We've long said that in order to provide the best possible start for babies, we must take care of moms, too.

Key Points: 
  • "We've long said that in order to provide the best possible start for babies, we must take care of moms, too.
  • "The health of moms and babies are intertwined and we welcome everyone to join this movement for change that will help us achieve real, measurable improvements.
  • We embrace anyone who wants to do more for moms and babiesand not just today, but every day."
  • Together, participants will unite to honor motherhood, babies and families in addition to supporting the March of Dimes mission.

March Of Dimes Names Dr. Michael Georgieff As 2020 Agnes Higgins Award Recipient

Retrieved on: 
Monday, February 1, 2021
Franklin D. Roosevelt, March of Dimes, Polio, Agnes, Agnes C. Higgins

"We are pleased to recognize Dr. Georgieff with the 2020 Agnes Higgins Award, which is part of March of Dimes' efforts to promote and advance science that can improve the health of all moms and babies," said Dr. Rahul Gupta, Chief Medical and Health Officer, Senior Vice President and Interim Chief Scientific Officer at March of Dimes.

Key Points: 
  • "We are pleased to recognize Dr. Georgieff with the 2020 Agnes Higgins Award, which is part of March of Dimes' efforts to promote and advance science that can improve the health of all moms and babies," said Dr. Rahul Gupta, Chief Medical and Health Officer, Senior Vice President and Interim Chief Scientific Officer at March of Dimes.
  • I am so thrilled and proud to be honored by an organization that I've admired for so long," said Dr. Georgieff.
  • Established in 1980, the Agnes Higgins Award honors the late Agnes Higgins of the Montreal Diet Dispensary for her innovation and years of service to improve maternal nutrition.
  • Find more information about the Agnes Higgins Award here .

Intravacc's Sabin Inactivated Polio vaccine (sIPV), out-licensed to LG Chem, receives WHO prequalification

Retrieved on: 
Thursday, January 21, 2021
Medical specialties, Medicine, Vaccination, Vaccines, Virology, Polio vaccine, Polio eradication, Vaccine, Polio, Pentavalent vaccine, Attenuated vaccine

The vaccine was developed by Intravacc for technology transfer to manufacturers in low- and middle-income countries in the context of the global polio eradication initiative.

Key Points: 
  • The vaccine was developed by Intravacc for technology transfer to manufacturers in low- and middle-income countries in the context of the global polio eradication initiative.
  • The company will supply the vaccine to 70 countries in the Middle East, Africa and Southeast Asia starting in January 2021.
  • Intravacc will receive milestones and low single digit royalties for its considerable role in the development of this vaccine.
  • To reduce the use of the virulent vaccine derived polioviruses, a switch to inactivated polio vaccines (IPV) was desired.

Intravacc's Sabin Inactivated Polio vaccine (sIPV), out-licensed to LG Chem, receives WHO prequalification

Retrieved on: 
Thursday, January 21, 2021
Medical specialties, Medicine, Vaccination, Vaccines, Virology, Polio vaccine, Polio eradication, Vaccine, Polio, Pentavalent vaccine, Attenuated vaccine

The vaccine was developed by Intravacc for technology transfer to manufacturers in low- and middle-income countries in the context of the global polio eradication initiative.

Key Points: 
  • The vaccine was developed by Intravacc for technology transfer to manufacturers in low- and middle-income countries in the context of the global polio eradication initiative.
  • The company will supply the vaccine to 70 countries in the Middle East, Africa and Southeast Asia starting in January 2021.
  • Intravacc will receive milestones and low single digit royalties for its considerable role in the development of this vaccine.
  • To reduce the use of the virulent vaccine derived polioviruses, a switch to inactivated polio vaccines (IPV) was desired.

Sabin Vaccine Institute Funds Researchers to Investigate COVID-19 Misinformation, Design Solutions to Increase Vaccine Acceptance

Retrieved on: 
Wednesday, January 13, 2021
Medical specialties, Vaccination, Medicine, Vaccine, Virology, Sabin Vaccine Institute, Vaccines, Polio

Through this support, Sabin is encouraging collaborative, on-the-ground relationships between academic researchers, health officials and local communities.

Key Points: 
  • Through this support, Sabin is encouraging collaborative, on-the-ground relationships between academic researchers, health officials and local communities.
  • "It is more important than ever to better understand vaccine acceptance in low- and middle-income countries, said Kaitlin Christenson, vice president of Vaccine Acceptance & Demand at Sabin.
  • The virtual study will employ multi-pronged community health worker interventions in the Mewat district of Haryana, India, to address barriers to vaccine acceptance.
  • The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation.